Real-Time Update: Sanofi ADR (SNY) Stock Navigates the Market with Up-to-Date Data
The stock of Sanofi ADR (SNY) has seen a 4.11% increase in the past week, with a 1.01% gain in the past month, and a
The stock of Sanofi ADR (SNY) has seen a 4.11% increase in the past week, with a 1.01% gain in the past month, and a
Sanofi ADR (NASDAQ: SNY) has a higher price-to-earnings ratio of 20.53x compared to its average ratio, The 36-month beta value for SNY is at 0.61.
The price-to-earnings ratio for Sanofi ADR (NASDAQ: SNY) is 19.80x, which is above its average ratio. Moreover, the 36-month beta value for SNY is 0.62.
Sanofi ADR (NASDAQ: SNY)’s stock price has soared by 0.38 in relation to previous closing price of 47.15. Nevertheless, the company has seen a loss
The price-to-earnings ratio for Sanofi ADR (NASDAQ: SNY) is above average at 20.70x, Company’s 36-month beta value is 0.62.Analysts have differing opinions on the stock,
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.